We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $168M
1-Year Est. Return 60.36%
This Fund
S&P 500
This Quarter Est. Return
+8.8%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$285M
AUM Growth
+$33.9M
Cap. Flow
-$13.6M
Cap. Flow %
-4.76%
Top 10 Hldgs %
67.96%
Holding
105
New
6
Increased
8
Reduced
23
Closed
13

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$2.84M
2
JAAA icon
Janus Henderson AAA CLO ETF
JAAA
+$1.6M
3
LXRX icon
Lexicon Pharmaceuticals
LXRX
+$890K
4
ZIMV
ZimVie
ZIMV
+$642K
5
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$515K

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$7.16M
2
VKTX icon
Viking Therapeutics
VKTX
+$2.17M
3
LK
Luckin Coffee Inc. American Depositary Shares
LK
+$2.11M
4
ICLO icon
Invesco AAA CLO Floating Rate Note ETF
ICLO
+$1.25M
5
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$876K

Sector Composition

Rank Sector Weight
1 Healthcare 30.38%
2 Materials 27.67%
3 Financials 18.32%
4 Communication Services 6.88%
5 Technology 3.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBM icon
51
IBM
IBM
$204B
$474K 0.17%
2,142
– –
EDIT icon
52
Editas Medicine
EDIT
$411M
$463K 0.16%
135,853
-41,147
-23% -$179K
KURA icon
53
Kura Oncology
KURA
$901M
$371K 0.13%
19,000
+9,000
+90% +$182K
LLY icon
54
Eli Lilly
LLY
$1.07T
$266K 0.09%
300
– –
ATYR
55
aTyr Pharma
ATYR
$48M
$189K 0.07%
+107,174
New +$195K
ARCH
56
DELISTED
Arch Resources, Inc.
ARCH
$187K 0.07%
1,110
-119
-10% -$16.4K
ADBE icon
57
Adobe
ADBE
$94.5B
$181K 0.06%
35
– –
LEGH icon
58
Legacy Housing
LEGH
$628M
$178K 0.06%
6,500
– –
CYPH
59
Cypherpunk Technologies Inc
CYPH
$66.7M
$168K 0.06%
65,328
-49,027
-43% -$120K
RVNC
60
DELISTED
Revance Therapeutics, Inc.
RVNC
$163K 0.06%
+31,355
New +$156K
NVDA icon
61
NVIDIA
NVDA
$4.76T
$155K 0.05%
1,280
– –
JNJ icon
62
Johnson & Johnson
JNJ
$641B
$149K 0.05%
922
– –
KO icon
63
Coca-Cola
KO
$362B
$144K 0.05%
2,000
-5,600
-74% -$383K
AVGO icon
64
Broadcom
AVGO
$1.82T
$122K 0.04%
710
– –
XFOR icon
65
X4 Pharmaceuticals
XFOR
$372M
$103K 0.04%
5,136
-897
-15% -$18.7K
EBC icon
66
Eastern Bankshares
EBC
$5.29B
$82K 0.03%
5,000
– –
IWP icon
67
iShares Russell Mid-Cap Growth ETF
IWP
$19.8B
$82K 0.03%
695
– –
TTE icon
68
TotalEnergies
TTE
$187B
$78K 0.03%
1,200
-400
-25% -$27.2K
DOW icon
69
Dow Inc
DOW
$20.8B
$66K 0.02%
1,206
-9,930
-89% -$524K
FSBW icon
70
FS Bancorp
FSBW
$323M
$65K 0.02%
1,460
-2,920
-67% -$122K
URI icon
71
United Rentals
URI
$70.2B
$63K 0.02%
78
– –
OXY icon
72
Occidental Petroleum
OXY
$54.6B
$58K 0.02%
1,249
– –
FSK icon
73
FS KKR Capital
FSK
$3.04B
$57K 0.02%
2,875
– –
BRSL
74
Brightstar Lottery PLC
BRSL
$1.93B
$53K 0.02%
2,500
-5,000
-67% -$107K
KVUE icon
75
Kenvue
KVUE
$37.4B
$52K 0.02%
2,235
– –
1 2
3
4 5

Similar funds

DI
Disciplined Investors Waco, Texas $168M AUM 23.6% 1-Year Est. Return
WFS
Widmann Financial Services Bowie, Maryland $168M AUM 24.36% 1-Year Est. Return
CCG
Catalina Capital Group Torrance, California $168M AUM 16.69% 1-Year Est. Return
7CM
7G Capital Management New York $168M AUM 45.68% 1-Year Est. Return
MAG
Meadowbrook Advisors Group Bedminster, New Jersey $168M AUM
PFA
Presper Financial Architects Akron, Ohio $168M AUM 12.94% 1-Year Est. Return
CW
Code Waechter Tampa, Florida $168M AUM 15.56% 1-Year Est. Return
IWA
Integrity Wealth Advisors Ventura, California $168M AUM 18.33% 1-Year Est. Return

David M. Knott Jr's Q3 2024 Portfolio in Review

As of Q3 2024, David M. Knott Jr held 105 positions worth $285M, up 14% from $251M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

David M. Knott Jr withdrew a net $13.6M in Q3 2024, closing 13 positions and reducing 23 holdings. Its most notable exit was Ligand Pharmaceuticals, an estimated $7.16M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 31% a quarter earlier, followed by Materials and Financials.

Against the trend, David M. Knott Jr opened a new position in BioMarin Pharmaceuticals worth $2.39M.

  • David M. Knott Jr's largest Q3 2024 buy was BioMarin Pharmaceuticals: 34,000 shares worth $2.39M.
  • David M. Knott Jr added most to Janus Henderson AAA CLO ETF in Q3 2024, an estimated $1.6M increase.
  • David M. Knott Jr's biggest Q3 2024 reduction was Viking Therapeutics, cutting an estimated $2.17M.
  • David M. Knott Jr fully exited Ligand Pharmaceuticals in Q3 2024, selling an estimated $7.16M.
  • David M. Knott Jr's ten largest holdings make up 68% of its $285M portfolio in Q3 2024.
  • David M. Knott Jr opened 6 new positions and closed 13 in Q3 2024.
  • David M. Knott Jr's portfolio value rose 14% quarter-over-quarter to $285M.

Based on David M. Knott Jr's 13F filing for Q3 2024, filed 13 Nov 2024.